AbCheck

Czechia
Slavkov pod Hostýnem, Zlín, Czechia
+420 378 05 15 00 ★

Company profile

AbCheck company profile

AbCheck provides an antibody discovery platform that discovers and optimizes human therapeutic antibodies. The company provides drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free agreements. It generates target-specific human antibody domains which can be used in distinct therapeutic formats. AbCheck was founded in 2009 and is a spin-out of Affimed’s technology discovery platform. It is a wholly owned subsidiary of Affimed GmbH, a biopharmaceutical company developing highly targeted cancer immunotherapies.

Business identity

Contact email
[email protected]
Phone number
+420 378 05 15 00
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2009-01-01

Headquarters

Headquarters
Slavkov pod Hostýnem, Zlín, Czechia
Postal code
301 00
Country code
CZ
Continent
Europe

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Last funding
Grant / $1.1M / 2023-03-09
Exited on
2024-01-03

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.